CryoPort, Inc. (CYRX) to Release Quarterly Earnings on Thursday
CryoPort, Inc. (NASDAQ:CYRX) is set to issue its quarterly earnings data after the market closes on Thursday, November 2nd. Analysts expect the company to announce earnings of ($0.08) per share for the quarter.
CryoPort (NASDAQ:CYRX) last announced its quarterly earnings results on Tuesday, August 8th. The company reported ($0.08) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.09) by $0.01. The company had revenue of $2.92 million for the quarter, compared to analysts’ expectations of $2.84 million. CryoPort had a negative net margin of 102.89% and a negative return on equity of 67.75%. On average, analysts expect CryoPort to post $-0.72 EPS for the current fiscal year and $-0.72 EPS for the next fiscal year.
Shares of CryoPort, Inc. (NASDAQ CYRX) traded up 0.27% during trading on Friday, hitting $7.39. 120,669 shares of the stock were exchanged. The firm’s 50 day moving average price is $8.89 and its 200-day moving average price is $5.81. CryoPort, Inc. has a 52 week low of $1.88 and a 52 week high of $10.40. The stock’s market cap is $182.34 million.
CYRX has been the subject of several recent analyst reports. Janney Montgomery Scott increased their price objective on shares of CryoPort from $10.00 to $12.00 and gave the stock a “buy” rating in a research report on Tuesday, October 3rd. Cowen and Company reiterated an “outperform” rating and set a $11.00 price objective (up from $7.50) on shares of CryoPort in a research report on Tuesday, September 12th. Finally, Needham & Company LLC increased their price objective on shares of CryoPort from $8.50 to $10.00 and gave the stock a “buy” rating in a research report on Wednesday, August 30th.
A hedge fund recently raised its stake in CryoPort stock. Northern Trust Corp lifted its position in shares of CryoPort, Inc. (NASDAQ:CYRX) by 105.0% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 22,179 shares of the company’s stock after buying an additional 11,358 shares during the quarter. Northern Trust Corp owned about 0.09% of CryoPort worth $109,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 12.12% of the company’s stock.
Cryoport, Inc (Cryoport) is a provider of cryogenic logistics solutions to the life sciences industry through its purpose-built packaging, information technology and specialized cold chain logistics expertise. The Company provides logistics solutions for biologic materials, such as immunotherapies, stem cells, chimeric antigen receptors (CAR)-T cells, and reproductive cells for clients.
Receive News & Ratings for CryoPort Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort Inc. and related companies with MarketBeat.com's FREE daily email newsletter.